TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway
Cytokine(2022)
摘要
•Silencing TRIM66 hindered cell malignant phenotype of non-small cell lung cancer;•TRIM66 interacted with MMP9 in non-small cell lung cancer;•MMP9 activated TGF-β/SMAD pathway;•TRIM66/MMP9/TGF-β/SMAD axis promoted non-small cell lung cancer progression.
更多查看译文
关键词
TRIM66,MMP9,EMT,TGF-β/SMAD pathway,NSCLC,Malignant phenotype
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要